Brain Structure Complexity Predicts DBS Outcomes in Parkinson's Disease
Author Information
Author(s): Schoen Devin, Deutsch Skyler, Mehta Juhi, Wang Sarah, Kornak John, Starr Philip, Wang Doris, Ostrem Jill, Bledsoe Ian, Morrison Melanie
Hypothesis
Can measures of brain structure predict changes in Parkinson's disease medications in response to deep brain stimulation?
Conclusion
The study found that brain structure complexity is linked to the effectiveness of deep brain stimulation in reducing medication burden for Parkinson's disease patients.
Supporting Evidence
- Fractal dimension was validated as a biomarker of Parkinson's disease progression.
- Significant differences in fractal dimension were found across nine brain regions.
- Inclusion of imaging features improved the predictive model for medication changes post-DBS.
Takeaway
Doctors can use brain scans to help decide if deep brain stimulation will work for people with Parkinson's disease.
Methodology
The study used preoperative T1-weighted MRI data to extract measures of fractal dimension and evaluated their predictive power for medication changes post-DBS.
Participant Demographics
Patients with Parkinson's disease, including various demographics such as age and sex.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website